Activation of 5-HT2A/2C receptors within the nucleus accumbens increases local dopaminergic transmission

Appel, 1990, Autoradiographic characterization of (±)-1-(2,5-dimethoxy-4-[125I]iodophenyl)-2-aminopropane ([125I]DOI) binding to 5-HT2 and 5-HT1C receptors in rat brain, J. Pharmacol. Exp. Ther., 255, 843

Awouters, 1985, The pharmacology of ketanserin, the first selective serotonin S2-antagonist, Drug Dev. Res., 6, 263, 10.1002/ddr.430060402

Bardo, 1998, Neuropharmacological mechanisms of drug reward, Crit. Rev. Neurobiol., 12, 37, 10.1615/CritRevNeurobiol.v12.i1-2.30

Blackburn, 1992, Dopamine functions in appetitive and defensive behaviours, Prog. Neurobiol., 39, 247, 10.1016/0301-0082(92)90018-A

Campbell, 1995, Serotonin-3 receptor and ethanol-stimulated dopamine release in the nucleus accumbens, Pharmacol Biochem Behav., 51, 835, 10.1016/0091-3057(95)00050-7

Chen, 1991, Activation of 5-HT3 receptor by 1-phenylbiguanide increases dopamine release in the rat nucleus accumbens, Brain Res., 543, 354, 10.1016/0006-8993(91)90050-6

Cohen, 1985, Receptor specificity of the 5-HT2 receptor antagonist, LY53857, Drug Dev. Res., 5, 313, 10.1002/ddr.430050404

Devaud, 1990, Effect of the 5-HT2 receptor antagonist, ritanserin, on biogenic amines in the rat nucleus accumbens, Eur. J. Pharmacol., 192, 427, 10.1016/0014-2999(91)90235-I

Devaud, 1992, Alterations in extracellular and tissue levels of biogenic amines in rat brain induced by the serotonin-2 receptor antagonist, ritanserin, J. Neurochem., 59, 1459, 10.1111/j.1471-4159.1992.tb08461.x

Di Matteo, 1998, Selective blockade of serotonin2C/2B receptors enhances dopamine release in the rat nucleus accumbens, Neuropharmacology, 37, 265, 10.1016/S0028-3908(98)00014-8

Fischette, 1987, Effects of 5,7-dihydroxytryptamine on serotonin1 and serotonin2 receptors through the rat central nervous system using quantitative autoradiography, Brain Res., 421, 263, 10.1016/0006-8993(87)91296-0

Guan, 1989, Serotonin microinfusion into the ventral tegmental area increases accumbens dopamine release, Brain Res. Bull., 23, 541, 10.1016/0361-9230(89)90198-6

Gobert, 1999, Serotonin (5-HT)2A receptor activation enhances dialysate levels of dopamine and noradrenaline, but not 5-HT, in the frontal cortex of freely-moving rats, Neuropharmacology, 38, 315, 10.1016/S0028-3908(98)00188-9

Hallbus, 1997, Influence of 5-HT1B/1D receptors on dopamine release in the guinea pig nucleus accumbens, Neurosci. Lett., 225, 57, 10.1016/S0304-3940(97)00178-X

Hoyer, 1997, 5-HT receptor classification and nomenclature, Neuropharmacology, 36, 419, 10.1016/S0028-3908(97)00036-1

Humphrey, 1993, A proposed new nomenclature for 5-HT receptors, Trends Pharmacol. Sci., 14, 233, 10.1016/0165-6147(93)90016-D

Hyman, 1996, Addiction to cocaine and amphetamine, Neuron, 16, 901, 10.1016/S0896-6273(00)80111-7

Koob, 1998, Neurocircuitry targets in ethanol reward and dependence, Alcohol. Clin. Exp. Res., 22, 3, 10.1111/j.1530-0277.1998.tb03611.x

Koob, 1992, Drugs of abuse, Trends Pharmacol. Sci., 13, 177, 10.1016/0165-6147(92)90060-J

Le Moal, 1991, Mesocorticolimbic dopaminergic network, Physiol. Rev., 71, 155, 10.1152/physrev.1991.71.1.155

Malgouris, 1993, Autoradiographic studies of RP 62203 a potent 5-HT2 receptor antagonist. In vitro and ex vivo selectivity profile, Eur. J. Pharmacol., 233, 29, 10.1016/0014-2999(93)90345-I

Meltzer, 1989, Clinical studies on the mechanism of action of clozapine, Psychopharmacology, 99, S18, 10.1007/BF00442554

Moore, 1978, Serotonin neurons in the midbrain raphe, J. Comp. Neurol., 180, 417, 10.1002/cne.901800302

Morilak, 1993, Immunocytochemical localization and description of neurons expressing serotonin2 receptors in the rat brain, Neuroscience, 54, 701, 10.1016/0306-4522(93)90241-7

Myers, 1993, 5-HT2 receptor blockade by amperozide suppress ethanol drinking in genetically preferring (P) rats, Pharmacol. Biochem. Behav., 45, 741, 10.1016/0091-3057(93)90535-2

Nakahara, 1994, Effect of nitric oxide on central dopamine neurons, Brain Nerve, 46, 1147

Nissbrandt, 1992, The influence of serotonergic drugs on dopaminergic neurotransmission in rat substantia nigra, striatum and limbic forebrain in vivo, Naunyn-Schmiedebergs Arch. Pharmacol., 346, 12, 10.1007/BF00167564

North, 1989, 5-Hydroxytryptamine acts 5-HT2 receptors to decrease potassium conductance in rat nucleus accumbens neurons, J. Physiol., 417, 1, 10.1113/jphysiol.1989.sp017786

Oades, 1987, Ventral tegmental (A10) system, Brain Res. Rev., 12, 117, 10.1016/0165-0173(87)90011-7

Panocka, 1992, Long-lasting suppression of alcohol preference in rats following serotonin receptor blockade by ritanserin, Brain Res. Bull., 28, 493, 10.1016/0361-9230(92)90052-Y

Parsons, 1993, Perfusate serotonin increases extracellular dopamine in the nucleus accumbens as measured by in vivo microdialysis, Brain Res., 606, 195, 10.1016/0006-8993(93)90984-U

Paxinos, 1986

Pessia, 1994, Actions of 5-hydroxytryptamine on ventral tegmental area neurons of the rat in vitro, Brain Res., 654, 324, 10.1016/0006-8993(94)90495-2

Prisco, 1994, Serotonin-dopamine interaction in the rat ventral tegmental area, J. Pharmacol. Exp. Ther., 271, 83

Schmidt, 1996, Regional effects of MK-801 on dopamine release, J. Pharmacol. Exp. Ther., 277, 1541

Ugedo, 1989, Ritanserin, a 5-HT2 receptor antagonist, activates midbrain dopamine neurons by blocking serotonergic inhibition, Psychopharmacology, 98, 45, 10.1007/BF00442004

Vertes, 1988, Autoradiographic analysis of ascending projections from the pontine and mesencephalic reticular formation and the median raphe nucleus in the rat, J. Comp. Neurol., 275, 511, 10.1002/cne.902750404

Weiss, 1993, Oral alcohol self-administration stimulates dopamine release in the rat nucleus accumbens, J. Pharmacol. Exp. Ther., 267, 250

West, 1996, Intrastriatal infusion of (±)-S-nitroso-N-acetylpenicillamine releases vesicular dopamine via an ionotropic glutamate receptor-mediated mechanism. An in vivo microdialysis study in chloral hydrate-anesthetized rats, J. Neurochem., 66, 1971, 10.1046/j.1471-4159.1996.66051971.x

West, 1999, Nitric oxide and potassium chloride-facilitated striatal dopamine efflux in vivo, Neurochem. Int., 33, 493, 10.1016/S0197-0186(98)00054-0

Westerink, 1987, The use of tetrodotoxin for the characterization of drug-enhanced dopamine release in conscious rats studied by brain dialysis, Naunyn-Schmiedebergs Arch. Pharmacol., 336, 502, 10.1007/BF00169306

Willins, 1998, Serotonin 5-HT2C agonists selectively inhibit morphine-induced dopamine efflux in the nucleus accumbens, Brain Res., 781, 291, 10.1016/S0006-8993(97)01267-5

Yoshimoto, 1992, Regulation of nucleus accumbens dopamine release by the dorsal raphe nucleus in the rat, Neurochem. Res., 17, 401, 10.1007/BF00969884